Healthcare IT

Image

Global Randomization and Trial Supply Management (RTSM) Market – Industry Trends and Forecast to 2029

  • Healthcare IT
  • Upcoming Report
  • Jun 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Randomization and Trial Supply Management (RTSM) Market, By Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions, Cloud-Based (SaaS) Solutions), Clinical Trial Phase (Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV Clinical Trials), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, Academic Research Institutes) – Industry Trends and Forecast to 2029

Randomization and Trial Supply Management (RTSM) Market

Market Analysis and Size

Randomization and trial supply management is abbreviated as RTSM. It's a technology solution that's utilised in clinical studies to manage drug distribution and control patient randomization. Randomization is an experimental control strategy that eliminates selection and unintentional bias.

Data Bridge Market Research analyses that the randomization and trial supply management (RTSM) market which was USD 0.17 billion in 2021, would rocket up to USD 0.52 billion by 2029, and is expected to undergo a CAGR of 15 % during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions, Cloud-Based (SaaS) Solutions), Clinical Trial Phase (Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV Clinical Trials), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, Academic Research Institutes)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

MEDICAL Information Technology Inc. (U.S), SAP (Germany), CPSI (U.S), Meta (U.S), Elinext (U.S), EPIC Systems Corporation (U.S), INFOR (U.S), Cognizant (U.S), Oracle (U.S), Jag products LLC (U.S), Allscripts Healthcare LLC (U.S), Optum Inc. (U.S), Cerner Corporation (U.S), Change Healthcare (U.S),  Koninklijke Philips N.V. (Netherlands), athenahealth (U.S), eClinicalWorks (U.S)

Market Opportunities

  • Improved preference for automated randomization and trial supply management (RTSM) practices
  • Increasing disposable incomes stimulate demand

Market Definition

Clinical studies use telephone and interactive voice response (IVR) technologies to manage randomization, study medication administration, and inventories using randomization and trial supply management (RTSM) systems.

 Randomization and Trial Supply Management (RTSM) Market Dynamics

Drivers

  • Rise in adoption of novel software solutions

Increasing adoption of novel software solutions, rising government funding for clinical trials, the introduction of e-clinical solutions to improve data standardisation, and rising pharmaceutical company expenditure for drug development pipeline allocation are some of the factors that will likely accelerate the growth of the randomization and trial supply management (RTSM) market, in the forecast period of 2022-2029.

  • increasing number of clinical trials

The increasing number of clinical trials in developing economies, as well as the outsourcing of clinical trial operations by many sectors, would enhance numerous opportunities for the randomization and trial supply management (RTSM) market throughout the forecast period.

Opportunities

Rising awareness among the patients regarding the prevailing advantages of management solutions will help in boosting lucrative opportunities in the growth of the market.

Restraints/Challenges

Lack of skilled professionals and high cost of implementation which will hamper the growth of the randomization and trial supply management (RTSM) market in the forecast period of 2022 to 2029.

This randomization and trial supply management (RTSM) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the randomization and trial supply management (RTSM) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Randomization and Trial Supply Management (RTSM) Market

The global market for clinical trials has been significantly impacted by the COVID-19 pandemic, since there has been a growing focus on creating novel treatments or vaccinations to combat or treat the disease. COVID-19 has also caused a modest alteration in the way clinical studies are conducted. Previously, there had been a surge in interest in virtual/decentralized trials in the worldwide clinical trials.

Global Randomization and Trial Supply Management (RTSM) Market Scope

The randomization and trial supply management (RTSM) market is segmented on the basis of delivery mode, clinical trial phase and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Delivery Mode

  • Web-Hosted (On-Demand) Solutions
  • Licensed Enterprise (On-Premise) Solutions
  • Cloud-Based (SaaS) Solutions

 Clinical Trial Phase

  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV Clinical Trials

End-User

  • Pharmaceutical
  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Consulting Service Companies
  • Medical Device Manufacturers
  • Hospitals
  • Academic Research Institutes

Randomization and Trial Supply Management (RTSM) Market Regional Analysis/Insights

The randomization and trial supply management (RTSM) market is analysed and market size insights and trends are provided by country, delivery mode, clinical trial phase and end-user as referenced above.

The countries covered in the randomization and trial supply management (RTSM) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the randomization and trial supply management (RTSM) market due to the growing occurrences of lifestyle diseases along with growing population and prevalence of improved infrastructure.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the prevalence of targeted diseases along with rising number of clinical trials.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Randomization and Trial Supply Management (RTSM) Market Share Analysis

The randomization and trial supply management (RTSM) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to randomization and trial supply management (RTSM) market.

Some of the major players operating in the randomization and trial supply management (RTSM) market are:

  • MEDICAL Information Technology Inc. (U.S)
  • SAP (Germany)
  • CPSI (U.S)
  • Meta (U.S)
  • Elinext (U.S)
  • EPIC Systems Corporation (U.S)
  • INFOR (U.S)
  • Cognizant (U.S)
  • Oracle (U.S)
  • Jag products LLC (U.S)
  • Allscripts Healthcare LLC (U.S)
  • Optum Inc. (U.S)
  • Cerner Corporation (U.S)
  • Change Healthcare (U.S)
  •  Koninklijke Philips N.V. (Netherlands)
  • athenahealth (U.S)
  • eClinicalWorks (U.S)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The randomization and trial supply management (RTSM) market value was USD 0.17 billion in 2021.
The Randomization and Trial Supply Management (RTSM) Market is to grow at a CAGR of 15% during the forecast by 2029.
The major players operating in the Randomization and Trial Supply Management (RTSM) Market are MEDICAL Information Technology Inc. (U.S), SAP (Germany), CPSI (U.S), Meta (U.S), Elinext (U.S), EPIC Systems Corporation (U.S), INFOR (U.S), Cognizant (U.S), Oracle (U.S), Jag products LLC (U.S), Allscripts Healthcare LLC (U.S), Optum Inc. (U.S), Cerner Corporation (U.S), Change Healthcare (U.S), Koninklijke Philips N.V. (Netherlands), athenahealth (U.S), eClinicalWorks (U.S).
The major countries covered in the Randomization and Trial Supply Management (RTSM) Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials